PREMIUM
AIM IHT
Benefit from the boom in healthcare Artificial Intelligence
This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, has been growing fast over recent years and looks compelling value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years.
IXICO (LON:XI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.
Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.
The Group is a…
Continue reading our content…
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
Register FREE for access to limited content.
- Company and markets insights
- Sponsored content
- Podcasts
Fundamental Asset Management
Buy any of our portfolios with our associates.
Previous article Next article
